Cannabis DADiRRi and Velvet Roots Apothecary launch botanical-infused pre-rolls High-grade cannabis and herbal blend mixture now crafted for morning, daytime and evening use Rowan DunneAugust 26, 2022
Canada Clearmind’s psychoactive drug shows positive results for cocaine use disorder Novel proprietary psychedelic molecule continues to demonstrate potential for treating cocaine dependency Rowan DunneAugust 26, 2022
Cannabis Glass House partners with Seed Junky to cultivate exclusive new strains Glass House will now assist Seed Junky with its mission of 'spreading the dank worldwide with game-changing cultivars' Rowan DunneAugust 25, 2022
Psychedelics MindMed announces initial patient dosing in MM-120 study Biopharmaceutical company administers optimized form of LSD in Phase 2b dose-optimization trial Rowan DunneAugust 25, 2022
Canada Nextleaf adds THC-free CBD distillate to Glacial Gold catalogue Rise & Shine CBD Drops will initially be available in British Columbia followed by national distribution this fall Rowan DunneAugust 24, 2022
Sleep Happy Health launches the Happy Ring Texas technology company announces US$60M in funding and waitlist for new wearable smart product Rowan DunneAugust 24, 2022
Cannabis Cannabis and psychedelic use among young people reaches all-time high in 2021: NIH Monitoring the Future panel study supported by the NIH outlines new statistics Rowan DunneAugust 24, 2022
International Mind Medicine Australia receives AUD$1M grant for psychedelic research New fund will support studies on psychedelic-assisted therapies for the treatment of mental health conditions Rowan DunneAugust 23, 2022
Cannabis Tilray receives approval for CBD oral solution in Australia and New Zealand Flagship product from company's medical cannabis division now set for clinical trial use Rowan DunneAugust 23, 2022
Canada Canntab Therapeutics enters the Nova Scotia cannabis marketplace Cannabinoid tablet supplier expands its Canadian distribution network Rowan DunneAugust 22, 2022